Offer - Urjas Oil for just ₹ 1 X
Orlishape 120 Capsule is a prescription drug, available for use as Capsule. Primarily, it is used for the treatment of Obesity.
The right dosage of Orlishape 120 Capsule depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Orlishape 120 Capsule as well, which are listed below. Usually, these side effects of Orlishape 120 Capsule go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Orlishape 120 Capsule is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Orlishape 120 Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Orlishape 120 Capsule related warnings section.
Some other conditions that can be affected by Orlishape 120 Capsule are listed in the contraindications section below.
Besides this, Orlishape 120 Capsule may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Orlishape 120 Capsule is safe while driving, and is addiction.
Orlishape 120 Capsule is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Orlishape 120 Capsule safe for pregnant women?
Orlishape should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Orlishape 120 Capsule safe during breastfeeding?
Orlishape should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Orlishape 120 Capsule on the Kidneys?
Orlishape does not damage the kidneys.
What is the effect of Orlishape 120 Capsule on the Liver?
Side effects of Orlishape rarely affect the liver.
What is the effect of Orlishape 120 Capsule on the Heart?
There are no any side effects of Orlishape for the heart.
Orlishape 120 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Orlishape 120 Capsule unless your doctor advises you to do so -
Is this Orlishape 120 Capsule habit forming or addictive?
No, there is no any evidence that Orlishape 120 Capsule is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Orlishape 120 Capsule does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Orlishape 120 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Orlishape 120 Capsule in mental disorders is not effective.
Interaction between Food and Orlishape 120 Capsule
Taking Orlishape 120 Capsule with food does not cause any problems.
Interaction between Alcohol and Orlishape 120 Capsule
Due to lack of research, there is no information about the side effects of taking Orlishape 120 Capsule with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xenical (orlistat)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 92-93
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 139